J Korean Assoc Oral Maxillofac Surg.  2022 Apr;48(2):71-78. 10.5125/jkaoms.2022.48.2.71.

Use of stem cells in bone regeneration in cleft palate patients: review and recommendations

• Amiri MA
• Lavaee F
• Danesteh H

• KMID: 2529919
• DOI: http://doi.org/10.5125/jkaoms.2022.48.2.71

Abstract

This study was conducted to review the efficacy of different sources of stem cells in bone regeneration of cleft palate patients. The majority of previous studies focused on the transplantation of bone marrow mesenchymal stem cells. However, other sources of stem cells have also gained considerable attention, and dental stem cells have shown especially favorable outcomes. Additionally, approaches that apply the co-culture and co-transplantation of stem cells have shown promising results. The use of different types of stem cells, based on their accessibility and efficacy in bone regeneration, is a promising method in cleft palate bone regeneration. In this regard, dental stem cells may be an ideal choice due to their efficacy and accessibility. In conclusion, stem cells, despite the lengthy procedures required for culture and preparation, are a suitable alternative to conventional bone grafting techniques.

Keyword

Cleft palate; Tissue engineering; Bone regeneration; Craniofacial abnormalities; Stem cells

Reference

References

1. Khazaei S, Shirani AM, Khazaei M, Najafi F. 2011; Incidence of cleft lip and palate in Iran. A meta-analysis. Saudi Med J. 32:390–3. PMID: 21483999.

2. Wu C, Pan W, Feng C, Su Z, Duan Z, Zheng Q, et al. 2018; Grafting materials for alveolar cleft reconstruction: a systematic review and best-evidence synthesis. Int J Oral Maxillofac Surg. 47:345–56. https://doi.org/10.1016/j.ijom.2017.08.003. DOI: 10.1016/j.ijom.2017.08.003. PMID: 28863859.

3. Koole R, Bosker H, van der Dussen FN. 1989; Late secondary autogenous bone grafting in cleft patients comparing mandibular (ectomesenchymal) and iliac crest (mesenchymal) grafts. J Craniomaxillofac Surg. 17 Suppl 1:28–30. https://doi.org/10.1016/s1010-5182(89)80036-8. DOI: 10.1016/S1010-5182(89)80036-8. PMID: 2606985.

4. Kilinc A, Saruhan N, Ertas U, Korkmaz IH, Kaymaz I. 2017; An analysis of mandibular symphyseal graft sufficiency for alveolar cleft bone grafting. J Craniofac Surg. 28:147–50. https://doi.org/10.1097/SCS.0000000000003274. DOI: 10.1097/SCS.0000000000003274. PMID: 27941546.

5. Weijs WL, Siebers TJ, Kuijpers-Jagtman AM, Bergé SJ, Meijer GJ, Borstlap WA. 2010; Early secondary closure of alveolar clefts with mandibular symphyseal bone grafts and beta-tri calcium phosphate (beta-TCP). Int J Oral Maxillofac Surg. 39:424–9. https://doi.org/10.1016/j.ijom.2010.02.004. DOI: 10.1016/j.ijom.2010.02.004. PMID: 20303237.

6. Mossaad A, Badry TE, Abdelrahaman M, Abdelazim A, Ghanem W, Hassan S, et al. 2019; Alveolar cleft reconstruction using different grafting techniques. Open Access Maced J Med Sci. 7:1369–73. https://doi.org/10.3889/oamjms.2019.236. DOI: 10.3889/oamjms.2019.236. PMID: 31110587. PMCID: PMC6514340.

7. Paganelli C, Fontana P, Porta F, Majorana A, Pazzaglia UE, Sapelli PL. 2006; Indications on suitable scaffold as carrier of stem cells in the alveoloplasty of cleft palate. J Oral Rehabil. 33:625–9. https://doi.org/10.1111/j.1365-2842.2005.01594.x. DOI: 10.1111/j.1365-2842.2005.01594.x. PMID: 16856961.

8. Mueller AA, Forraz N, Gueven S, Atzeni G, Degoul O, Pagnon-Minot A, et al. 2014; Osteoblastic differentiation of Wharton jelly biopsy specimens and their mesenchymal stromal cells after serum-free culture. Plast Reconstr Surg. 134:59e–69e. https://doi.org/10.1097/PRS.0000000000000305. DOI: 10.1097/PRS.0000000000000305. PMID: 25028857.

9. Kotobuki N, Hirose M, Machida H, Katou Y, Muraki K, Takakura Y, et al. 2005; Viability and osteogenic potential of cryopreserved human bone marrow-derived mesenchymal cells. Tissue Eng. 11:663–73. https://doi.org/10.1089/ten.2005.11.663. DOI: 10.1089/ten.2005.11.663. PMID: 15998208.

10. Baba K, Yamazaki Y, Ikemoto S, Aoyagi K, Takeda A, Uchinuma E. 2012; Osteogenic potential of human umbilical cord-derived mesenchymal stromal cells cultured with umbilical cord blood-derived autoserum. J Craniomaxillofac Surg. 40:768–72. https://doi.org/10.1016/j.jcms.2012.02.006. DOI: 10.1016/j.jcms.2012.02.006. PMID: 22503080.

11. Sahai S, Wilkerson M, Xue H, Moreno N, Carrillo L, Flores R, et al. 2020; Wharton's jelly for augmented cleft palate repair in a rat critical-size alveolar bone defect model. Tissue Eng Part A. 26:591–601. https://doi.org/10.1089/ten.TEA.2019.0254. DOI: 10.1089/ten.tea.2019.0254. PMID: 31739755.

12. Sun XC, Wang H, Li JH, Zhang D, Yin LQ, Yan YF, et al. 2020; Repair of alveolar cleft bone defects by bone collagen particles combined with human umbilical cord mesenchymal stem cells in rabbit. Biomed Eng Online. 19:62. https://doi.org/10.1186/s12938-020-00800-4. DOI: 10.1186/s12938-020-00800-4. PMID: 32746926. PMCID: PMC7397686.

13. Caballero M, Morse JC, Halevi AE, Emodi O, Pharaon MR, Wood JS, et al. 2015; Juvenile swine surgical alveolar cleft model to test novel autologous stem cell therapies. Tissue Eng Part C Methods. 21:898–908. https://doi.org/10.1089/ten.TEC.2014.0646. DOI: 10.1089/ten.tec.2014.0646. PMID: 25837453. PMCID: PMC4553376.

14. Caballero M, Jones DC, Shan Z, Soleimani S, van Aalst JA. 2017; Tissue engineering strategies to improve osteogenesis in the juvenile swine alveolar cleft model. Tissue Eng Part C Methods. 23:889–99. https://doi.org/10.1089/ten.TEC.2017.0148. DOI: 10.1089/ten.tec.2017.0148. PMID: 28747097. PMCID: PMC5734164.

15. Garcia BA, Prada MR, Ávila-Portillo LM, Rojas HN, Gómez-Ortega V, Menze E. 2019; New technique for closure of alveolar cleft with umbilical cord stem cells. J Craniofac Surg. 30:663–6. https://doi.org/10.1097/SCS.0000000000004967. DOI: 10.1097/SCS.0000000000004967. PMID: 30507877.

16. Mazzetti MPV, Alonso N, Brock RS, Ayoub A, Massumoto SM, Eça LP. 2018; Importance of stem cell transplantation in cleft lip and palate surgical treatment protocol. J Craniofac Surg. 29:1445–51. https://doi.org/10.1097/SCS.0000000000004766. DOI: 10.1097/SCS.0000000000004766. PMID: 30067525.

17. Pourebrahim N, Hashemibeni B, Shahnaseri S, Torabinia N, Mousavi B, Adibi S, et al. 2013; A comparison of tissue-engineered bone from adipose-derived stem cell with autogenous bone repair in maxillary alveolar cleft model in dogs. Int J Oral Maxillofac Surg. 42:562–8. https://doi.org/10.1016/j.ijom.2012.10.012. DOI: 10.1016/j.ijom.2012.10.012. PMID: 23219713.

18. Shahnaseri S, Sheikhi M, Hashemibeni B, Mousavi SA, Soltani P. 2020; Comparison of autogenous bone graft and tissue-engineered bone graft in alveolar cleft defects in canine animal models using digital radiography. Indian J Dent Res. 31:118–23. https://doi.org/10.4103/ijdr.IJDR_156_18. DOI: 10.4103/ijdr.IJDR_156_18. PMID: 32246693.

19. Sasayama S, Hara T, Tanaka T, Honda Y, Baba S. 2018; Osteogenesis of multipotent progenitor cells using the epigallocatechin gallate-modified gelatin sponge scaffold in the rat congenital cleft-jaw model. Int J Mol Sci. 19:3803. https://doi.org/10.3390/ijms19123803. DOI: 10.3390/ijms19123803. PMID: 30501071. PMCID: PMC6320852.

20. Lee SJ, Kim BJ, Kim YI, Sohn CH, Jeon YK, Xu L, et al. 2016; Effect of recombinant human bone morphogenetic protein-2 and adipose tissue-derived stem cell on new bone formation in high-speed distraction osteogenesis. Cleft Palate Craniofac J. 53:84–92. https://doi.org/10.1597/12-290. DOI: 10.1597/12-290. PMID: 23952562.

21. Chen L, Lu X, Li S, Sun Q, Li W, Song D. 2012; Sustained delivery of BMP-2 and platelet-rich plasma-released growth factors contributes to osteogenesis of human adipose-derived stem cells. Orthopedics. 35:e1402–9. https://doi.org/10.3928/01477447-20120822-29. DOI: 10.3928/01477447-20120822-29. PMID: 22955409.

22. Khojasteh A, Kheiri L, Behnia H, Tehranchi A, Nazeman P, Nadjmi N, et al. 2017; Lateral ramus cortical bone plate in alveolar cleft osteoplasty with concomitant use of buccal fat pad derived cells and autogenous bone: phase I clinical trial. Biomed Res Int. 2017:6560234. https://doi.org/10.1155/2017/6560234. DOI: 10.1155/2017/6560234. PMID: 29379800. PMCID: PMC5742895.

23. Lei SH, Guo L, Yue HY, Zhao DC, Zhang CJ, Du WJ, et al. 2013; Marrow stromal stem cell autologous transplantation in denervated fracture healing: an experimental study in rats. Orthop Surg. 5:280–8. https://doi.org/10.1111/os.12071. DOI: 10.1111/os.12071. PMID: 24254452. PMCID: PMC6583111.

24. Soltan M, Smiler D, Choi JH. 2009; Bone marrow: orchestrated cells, cytokines, and growth factors for bone regeneration. Implant Dent. 18:132–41. https://doi.org/10.1097/ID.0b013e3181990e75. DOI: 10.1097/ID.0b013e3181990e75. PMID: 19359864.

25. Pavan Kumar B, Ram Mohan S, Mohan AP, Jeevan Kumar KA, Yashwanth Yadav B. 2016; Versatility of pleuripotent undifferentiated stem cells aspirated from bone marrow and its applications in oral and maxillofacial surgery. J Maxillofac Oral Surg. 15:1–11. https://doi.org/10.1007/s12663-015-0793-2. DOI: 10.1007/s12663-015-0793-2. PMID: 26929546. PMCID: PMC4759021.

26. Al-Ahmady HH, Abd Elazeem AF, Bellah Ahmed NE, Shawkat WM, Elmasry M, Abdelrahman MA, et al. 2018; Combining autologous bone marrow mononuclear cells seeded on collagen sponge with nano hydroxyapatite, and platelet-rich fibrin: reporting a novel strategy for alveolar cleft bone regeneration. J Craniomaxillofac Surg. 46:1593–600. https://doi.org/10.1016/j.jcms.2018.05.049. DOI: 10.1016/j.jcms.2018.05.049. PMID: 30196860.

27. Du F, Wu H, Li H, Cai L, Wang Q, Liu X, et al. 2017; Bone marrow mononuclear cells combined with beta-tricalcium phosphate granules for alveolar cleft repair: a 12-month clinical study. Sci Rep. 7:13773. https://doi.org/10.1038/s41598-017-12602-1. DOI: 10.1038/s41598-017-12602-1. PMID: 29062005. PMCID: PMC5653813.

28. Zhang D, Chu F, Yang Y, Xia L, Zeng D, Uludağ H, et al. 2011; Orthodontic tooth movement in alveolar cleft repaired with a tissue engineering bone: an experimental study in dogs. Tissue Eng Part A. 17:1313–25. https://doi.org/10.1089/ten.TEA.2010.0490. DOI: 10.1089/ten.tea.2010.0490. PMID: 21226625.

29. Bajestan MN, Rajan A, Edwards SP, Aronovich S, Cevidanes LHS, Polymeri A, et al. 2017; Stem cell therapy for reconstruction of alveolar cleft and trauma defects in adults: a randomized controlled, clinical trial. Clin Implant Dent Relat Res. 19:793–801. https://doi.org/10.1111/cid.12506. DOI: 10.1111/cid.12506. PMID: 28656723.

30. Stanko P, Mracna J, Stebel A, Usakova V, Smrekova M, Vojtassak J. 2013; Mesenchymal stem cells - a promising perspective in the orofacial cleft surgery. Bratisl Lek Listy. 114:50–2. https://doi.org/10.4149/bll_2013_012. DOI: 10.4149/BLL_2013_012. PMID: 23331197.

31. Korn P, Hauptstock M, Range U, Kunert-Keil C, Pradel W, Lauer G, et al. 2017; Application of tissue-engineered bone grafts for alveolar cleft osteoplasty in a rodent model. Clin Oral Investig. 21:2521–34. https://doi.org/10.1007/s00784-017-2050-1. DOI: 10.1007/s00784-017-2050-1. PMID: 28101680.

32. Korn P, Schulz MC, Range U, Lauer G, Pradel W. 2014; Efficacy of tissue engineered bone grafts containing mesenchymal stromal cells for cleft alveolar osteoplasty in a rat model. J Craniomaxillofac Surg. 42:1277–85. https://doi.org/10.1016/j.jcms.2014.03.010. DOI: 10.1016/j.jcms.2014.03.010. PMID: 24831850.

33. Bara JJ, McCarthy HE, Humphrey E, Johnson WE, Roberts S. 2014; Bone marrow-derived mesenchymal stem cells become antiangiogenic when chondrogenically or osteogenically differentiated: implications for bone and cartilage tissue engineering. Tissue Eng Part A. 20:147–59. https://doi.org/10.1089/ten.tea.2013.0196. DOI: 10.1089/ten.tea.2013.0196. PMID: 23895198.

34. Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Atashi A. 2012; Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report. J Craniomaxillofac Surg. 40:2–7. https://doi.org/10.1016/j.jcms.2011.02.003. DOI: 10.1016/j.jcms.2011.02.003. PMID: 21420310.

35. Yoshioka M, Tanimoto K, Tanne Y, Sumi K, Awada T, Oki N, et al. 2012; Bone regeneration in artificial jaw cleft by use of carbonated hydroxyapatite particles and mesenchymal stem cells derived from iliac bone. Int J Dent. 2012:352510. https://doi.org/10.1155/2012/352510. DOI: 10.1155/2012/352510. PMID: 22536240. PMCID: PMC3320030.

36. Tanimoto K, Sumi K, Yoshioka M, Oki N, Tanne Y, Awada T, et al. 2015; Experimental tooth movement into new bone area regenerated by use of bone marrow-derived mesenchymal stem cells. Cleft Palate Craniofac J. 52:386–94. https://doi.org/10.1597/12-232. DOI: 10.1597/12-232. PMID: 23782420.

37. Naudot M, Davrou J, Djebara AE, Barre A, Lavagen N, Lardière S, et al. 2020; Functional validation of a new alginate-based hydrogel scaffold combined with mesenchymal stem cells in a rat hard palate cleft model. Plast Reconstr Surg Glob Open. 8:e2743. https://doi.org/10.1097/GOX.0000000000002743. DOI: 10.1097/GOX.0000000000002743. PMID: 32440413. PMCID: PMC7209877.

38. Ahn G, Lee JS, Yun WS, Shim JH, Lee UL. 2018; Cleft alveolus reconstruction using a three-dimensional printed bioresorbable scaffold with human bone marrow cells. J Craniofac Surg. 29:1880–3. https://doi.org/10.1097/SCS.0000000000004747. DOI: 10.1097/SCS.0000000000004747. PMID: 30028404.

39. Gimbel M, Ashley RK, Sisodia M, Gabbay JS, Wasson KL, Heller J, et al. 2007; Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J Craniofac Surg. 18:895–901. https://doi.org/10.1097/scs.0b013e3180a771af. DOI: 10.1097/scs.0b013e3180a771af. PMID: 17667684.

40. Hibi H, Yamada Y, Ueda M, Endo Y. 2006; Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg. 35:551–5. https://doi.org/10.1016/j.ijom.2005.12.007. DOI: 10.1016/j.ijom.2005.12.007. PMID: 16584868.

41. Tavakolinejad S, Ebrahimzadeh Bidskan A, Ashraf H, Hamidi Alamdari D. 2014; A glance at methods for cleft palate repair. Iran Red Crescent Med J. 16:e15393. https://doi.org/10.5812/ircmj.15393. DOI: 10.5812/ircmj.15393. PMID: 25593724. PMCID: PMC4270645.

42. Zhao YH, Zhang M, Liu NX, Lv X, Zhang J, Chen FM, et al. 2013; The combined use of cell sheet fragments of periodontal ligament stem cells and platelet-rich fibrin granules for avulsed tooth reimplantation. Biomaterials. 34:5506–20. https://doi.org/10.1016/j.biomaterials.2013.03.079. DOI: 10.1016/j.biomaterials.2013.03.079. PMID: 23639531.

43. Martín-Del-Campo M, Rosales-Ibañez R, Rojo L. 2019; Biomaterials for cleft lip and palate regeneration. Int J Mol Sci. 20:2176. https://doi.org/10.3390/ijms20092176. DOI: 10.3390/ijms20092176. PMID: 31052503. PMCID: PMC6540257.

44. Huang J, Tian B, Chu F, Yang C, Zhao J, Jiang X, et al. 2015; Rapid maxillary expansion in alveolar cleft repaired with a tissue-engineered bone in a canine model. J Mech Behav Biomed Mater. 48:86–99. https://doi.org/10.1016/j.jmbbm.2015.03.029. DOI: 10.1016/j.jmbbm.2015.03.029. PMID: 25913611.

45. Isono H, Kaida K, Hamada Y, Kokubo Y, Ishihara M, Hirashita A, et al. 2002; The reconstruction of bilateral clefts using endosseous implants after bone grafting. Am J Orthod Dentofacial Orthop. 121:403–10. https://doi.org/10.1067/mod.2002.121364. DOI: 10.1067/mod.2002.121364. PMID: 11997765.

46. Chung VH, Chen AY, Jeng LB, Kwan CC, Cheng SH, Chang SC. 2012; Engineered autologous bone marrow mesenchymal stem cells: alternative to cleft alveolar bone graft surgery. J Craniofac Surg. 23:1558–63. https://doi.org/10.1097/SCS.0b013e31825e4e30. DOI: 10.1097/SCS.0b013e31825e4e30. PMID: 22976660.

47. Lee JM, Kim HY, Park JS, Lee DJ, Zhang S, Green DW, et al. 2019; Developing palatal bone using human mesenchymal stem cell and stem cells from exfoliated deciduous teeth cell sheets. J Tissue Eng Regen Med. 13:319–27. https://doi.org/10.1002/term.2811. DOI: 10.1002/term.2811. PMID: 30644640.

48. Du Y, Jiang F, Liang Y, Wang Y, Zhou W, Pan Y, et al. 2016; The angiogenic variation of skeletal site-specific human BMSCs from same alveolar cleft patients: a comparative study. J Mol Histol. 47:153–68. https://doi.org/10.1007/s10735-016-9662-7. DOI: 10.1007/s10735-016-9662-7. PMID: 26846721.

49. Dong W, Zhang P, Fu Y, Ge J, Cheng J, Yuan H, et al. 2015; Roles of SATB2 in site-specific stemness, autophagy and senescence of bone marrow mesenchymal stem cells. J Cell Physiol. 230:680–90. https://doi.org/10.1002/jcp.24792. DOI: 10.1002/jcp.24792. PMID: 25200657.

50. Nakajima K, Kunimatsu R, Ando K, Ando T, Hayashi Y, Kihara T, et al. 2018; Comparison of the bone regeneration ability between stem cells from human exfoliated deciduous teeth, human dental pulp stem cells and human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 497:876–82. https://doi.org/10.1016/j.bbrc.2018.02.156. DOI: 10.1016/j.bbrc.2018.02.156. PMID: 29477844.

51. Tanikawa DYS, Pinheiro CCG, Almeida MCA, Oliveira CRGCM, Coudry RA, Rocha DL, et al. 2020; Deciduous dental pulp stem cells for maxillary alveolar reconstruction in cleft lip and palate patients. Stem Cells Int. 2020:6234167. https://doi.org/10.1155/2020/6234167. DOI: 10.1155/2020/6234167. PMID: 32256610. PMCID: PMC7091546.

52. Jahanbin A, Rashed R, Alamdari DH, Koohestanian N, Ezzati A, Kazemian M, et al. 2016; Success of maxillary alveolar defect repair in rats using osteoblast-differentiated human deciduous dental pulp stem cells. J Oral Maxillofac Surg. 74:829.e1–9. https://doi.org/10.1016/j.joms.2015.11.033. DOI: 10.1016/j.joms.2015.11.033. PMID: 26763080.

53. Wongsupa N, Nuntanaranont T, Kamolmattayakul S, Thuaksuban N. 2017; Biological characteristic effects of human dental pulp stem cells on poly-ε-caprolactone-biphasic calcium phosphate fabricated scaffolds using modified melt stretching and multilayer deposition. J Mater Sci Mater Med. 28:25. https://doi.org/10.1007/s10856-016-5833-z. DOI: 10.1007/s10856-016-5833-z. PMID: 28070691.

54. Berger M, Probst F, Schwartz C, Cornelsen M, Seitz H, Ehrenfeld M, et al. 2015; A concept for scaffold-based tissue engineering in alveolar cleft osteoplasty. J Craniomaxillofac Surg. 43:830–6. https://doi.org/10.1016/j.jcms.2015.04.023. DOI: 10.1016/j.jcms.2015.04.023. PMID: 26027868.

55. Hixon KR, Melvin AM, Lin AY, Hall AF, Sell SA. 2017; Cryogel scaffolds from patient-specific 3D-printed molds for personalized tissue-engineered bone regeneration in pediatric cleft-craniofacial defects. J Biomater Appl. 32:598–611. https://doi.org/10.1177/0885328217734824. DOI: 10.1177/0885328217734824. PMID: 28980856.

56. Martín-Piedra MA, Alaminos M, Fernández-Valadés-Gámez R, España-López A, Liceras-Liceras E, Sánchez-Montesinos I, et al. 2017; Development of a multilayered palate substitute in rabbits: a histochemical ex vivo and in vivo analysis. Histochem Cell Biol. 147:377–88. https://doi.org/10.1007/s00418-016-1489-5. DOI: 10.1007/s00418-016-1489-5. PMID: 27600719.

57. Pinheiro CCG, de Pinho MC, Aranha AC, Fregnani E, Bueno DF. 2018; Low power laser therapy: a strategy to promote the osteogenic differentiation of deciduous dental pulp stem cells from cleft lip and palate patients. Tissue Eng Part A. 24:569–75. https://doi.org/10.1089/ten.TEA.2017.0115. DOI: 10.1089/ten.tea.2017.0115. PMID: 28699387.

58. Park JS, Park KH. 2016; Light enhanced bone regeneration in an athymic nude mouse implanted with mesenchymal stem cells embedded in PLGA microspheres. Biomater Res. 20:4. https://doi.org/10.1186/s40824-016-0051-9. DOI: 10.1186/s40824-016-0051-9. PMID: 26893909. PMCID: PMC4758155.

59. Bueno DF, Kerkis I, Costa AM, Martins MT, Kobayashi GS, Zucconi E, et al. 2009; New source of muscle-derived stem cells with potential for alveolar bone reconstruction in cleft lip and/or palate patients. Tissue Eng Part A. 15:427–35. https://doi.org/10.1089/ten.tea.2007.0417. DOI: 10.1089/ten.tea.2007.0417. PMID: 18816169.

60. Fliefel R, Ehrenfeld M, Otto S. 2018; Induced pluripotent stem cells (iPSCs) as a new source of bone in reconstructive surgery: a systematic review and meta-analysis of preclinical studies. J Tissue Eng Regen Med. 12:1780–97. https://doi.org/10.1002/term.2697. DOI: 10.1002/term.2697. PMID: 29763985.

61. He Y, Lin S, Ao Q, He X. 2020; The co-culture of ASCs and EPCs promotes vascularized bone regeneration in critical-sized bone defects of cranial bone in rats. Stem Cell Res Ther. 11:338. https://doi.org/10.1186/s13287-020-01858-6. DOI: 10.1186/s13287-020-01858-6. PMID: 32746906. PMCID: PMC7398348.

62. Wu L, Zhao X, He B, Jiang J, Xie XJ, Liu L. 2016; The possible roles of biological bone constructed with peripheral blood derived EPCs and BMSCs in osteogenesis and angiogenesis. Biomed Res Int. 2016:8168943. https://doi.org/10.1155/2016/8168943. DOI: 10.1155/2016/8168943. PMID: 27195296. PMCID: PMC4852345.

63. Inglis S, Christensen D, Wilson DI, Kanczler JM, Oreffo RO. 2016; Human endothelial and foetal femur-derived stem cell co-cultures modulate osteogenesis and angiogenesis. Stem Cell Res Ther. 7:13. https://doi.org/10.1186/s13287-015-0270-3. DOI: 10.1186/s13287-015-0270-3. PMID: 26781715. PMCID: PMC4717648.

64. Seebach C, Henrich D, Wilhelm K, Barker JH, Marzi I. 2012; Endothelial progenitor cells improve directly and indirectly early vascularization of mesenchymal stem cell-driven bone regeneration in a critical bone defect in rats. Cell Transplant. 21:1667–77. https://doi.org/10.3727/096368912X638937. DOI: 10.3727/096368912X638937. PMID: 22507568.

65. Wang J, Ye Y, Tian H, Yang S, Jin X, Tong W, et al. 2011; In vitro osteogenesis of human adipose-derived stem cells by coculture with human umbilical vein endothelial cells. Biochem Biophys Res Commun. 412:143–9. https://doi.org/10.1016/j.bbrc.2011.07.062. DOI: 10.1016/j.bbrc.2011.07.062. PMID: 21806974.

66. Rong Q, Li S, Zhou Y, Geng Y, Liu S, Wu W, et al. 2020; A novel method to improve the osteogenesis capacity of hUCMSCs with dual-directional pre-induction under screened co-culture conditions. Cell Prolif. 53:e12740. https://doi.org/10.1111/cpr.12740. DOI: 10.1111/cpr.12740. PMID: 31820506. PMCID: PMC7078770.

67. Kim J, Kim HN, Lim KT, Kim Y, Pandey S, Garg P, et al. 2013; Synergistic effects of nanotopography and co-culture with endothelial cells on osteogenesis of mesenchymal stem cells. Biomaterials. 34:7257–68. https://doi.org/10.1016/j.biomaterials.2013.06.029. DOI: 10.1016/j.biomaterials.2013.06.029. PMID: 23834896.